NCT03919591View on ClinicalTrials.gov

RSV Study in Adults 60 to 75 Years of Age

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 12, 2019

Primary Completion Date

July 11, 2019

Study Completion Date

July 11, 2019

Conditions
RSV Infection
Interventions
OTHER

Challenge virus RSV-A Memphis 37b

Each subject will receive one titre of virus, which will be up to approximately 4.5 log10 PFU.

Trial Locations (1)

E1 2AX

hVIVO Services Limited, London

Sponsors

Lead Sponsor

Hvivo

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Hvivo

INDUSTRY

NCT03919591 - RSV Study in Adults 60 to 75 Years of Age | Biotech Hunter | Biotech Hunter